glp 1 benefits Can one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonists Cardiovascular benefits of glucagon-like peptide-1

Cellular distribution studies of the nitric oxide-generating antineoplastic prodrug O(2)-(2,4-dinitrophenyl)1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate formulated in Pluronic P123 micelles

Renal effects, including acute kidney injury, have been reported rarely in post-marketing surveillance, typically in the context of severe gastrointestinal adverse effects leading to dehydration

CJC-1295 No DAC stimulates the GHRH receptor via cAMP-dependent pathways, while Ipamorelin activates the GHSR-1a receptor through calcium-mediated signaling

doi:10.1007/s11920-006-0056-5CrossRefGoogle ScholarPubMed Johnson, KP, Malow, BA